ÂÜÀòÂÒÂ×

Fred T. Fiedorek is an accomplished medical professional with extensive experience in clinical drug development and leadership roles within the pharmaceutical industry. Currently serving as Chief Medical Officer at Verve Therapeutics, Fred has held positions at several notable organizations including Atlas Venture NewCo, Intarcia Therapeutics, and Bristol-Myers Squibb, where significant contributions were made to the development of therapies for cardiovascular and metabolic conditions. Fred's expertise spans endocrinology, metabolism, and internal medicine, supported by an academic background as an Assistant Professor at the University of North Carolina at Chapel Hill and prior research at Washington University School of Medicine. Educational credentials include an MD from Harvard Medical School and a BA from Yale University.